The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.
GMO International Equity III GMOIX
- NAV / 1-Day Return 24.60 / +0.74 %
- Total Assets 960.0 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.670%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 35.0 Mil
- Status Open
- TTM Yield 7.36%
- Turnover 51%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:15 PM GMT+0
Morningstar’s Analysis GMOIX
Will GMOIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
GMO US Treasury | 6.98 | 71.3 Mil | — |
TotalEnergies SE | 3.16 | 32.3 Mil | Energy |
Novartis AG ADR | 2.65 | 27.1 Mil | Healthcare |
Banco Bilbao Vizcaya Argentaria SA | 2.64 | 27.0 Mil | Financial Services |
Japan Tobacco Inc | 2.63 | 26.9 Mil | Consumer Defensive |
Sanofi SA | 2.43 | 24.9 Mil | Healthcare |
Compagnie de Saint-Gobain SA | 2.40 | 24.6 Mil | Industrials |
STMicroelectronics NV ADR | 2.39 | 24.5 Mil | Technology |
Industria De Diseno Textil SA Share From Split | 2.38 | 24.3 Mil | Consumer Cyclical |
British American Tobacco PLC | 2.36 | 24.2 Mil | Consumer Defensive |